The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Pervushina E.V.

Bashkir state medical university

Kutlubaev M.A.

Bashkir State Medical University

Saifullina E.V.

Bashkir State Medical University

Gaisina E.V.

Republican Medical and Genetic Center

Smakova L.A.

Institute of Biochemistry and Genetics of Ufa Federal Scientific Center

Khidiyatova I.M.

Institute of Biochemistry and Genetics of Ufa Federal Scientific Center;
Ufa University of Science and Technology;
Saint-Petersburg State University

Amyotrophic lateral sclerosis associated with a new pathogenic variant of the ERBB4 gene

Authors:

Pervushina E.V., Kutlubaev M.A., Saifullina E.V., Gaisina E.V., Smakova L.A., Khidiyatova I.M.

More about the authors

Read: 1013 times


To cite this article:

Pervushina EV, Kutlubaev MA, Saifullina EV, Gaisina EV, Smakova LA, Khidiyatova IM. Amyotrophic lateral sclerosis associated with a new pathogenic variant of the ERBB4 gene. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;124(7):165‑168. (In Russ.)
https://doi.org/10.17116/jnevro2024124071165

Recommended articles:
Oculomotor diso­rders in patients with amyotrophic late­ral scle­rosis. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(4):7-12
Sporadic form of Guam disease (ALS—parkinsonism—dementia complex). S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(7):135-141

References:

  1. Andersen PM, Al-Chalabi A. Clinical genetics of amyotrophic lateral sclerosis: what do we really know? Nat Rev Neurol. 2011;7(11):603-615.  https://doi.org/10.1038/nrneurol.2011.150
  2. Chiò A, Battistini S, Calvo A, et al. Genetic counselling in ALS: facts, uncertainties and clinical suggestions. J Neurol Neurosurg Psychiatry. 2014;85(5):478-485.  https://doi.org/10.1136/jnnp-2013-305546
  3. Takahashi Y, Fukuda Y, Yoshimura J, et al. ERBB4 mutations that disrupt the neuregulin-ErbB4 pathway cause amyotrophic lateral sclerosis type 19. Am J Hum Genet. 2013;93(5):900-905.  https://doi.org/10.1016/j.ajhg.2013.09.008
  4. Kataria H, Alizadeh A, Karimi-Abdolrezaee S. Neuregulin-1/ErbB network: An emerging modulator of nervous system injury and repair. Prog Neurobiol. 2019;180:101643. https://doi.org/10.1016/j.pneurobio.2019.101643
  5. Lopez-Font I, Sogorb-Esteve A, Javier-Torrent M. Decreased circulating ErbB4 ectodomain fragments as a read-out of impaired signaling function in amyotrophic lateral sclerosis. Neurobiol Dis. 2019;124:428-438.  https://doi.org/10.1016/j.nbd.2018.12.021
  6. Takahashi Y, Uchino A, Shioya A, et al. Altered immunoreactivity of ErbB4, a causative gene product for ALS19, in the spinal cord of patients with sporadic ALS. Neuropathology. 2019;39(4):268-278.  https://doi.org/10.1111/neup.12558
  7. Ilieva H, Vullaganti M, Kwan J. Advances in molecular pathology, diagnosis, and treatment of amyotrophic lateral sclerosis. BMJ. 2023;383:e075037. https://doi.org/10.1136/bmj-2023-075037
  8. Al-Chalabi A, van den Berg LH, Veldink J. Gene discovery in amyotrophic lateral sclerosis: implications for clinical management. Nat Rev Neurol. 2017;13(2):96-104.  https://doi.org/10.1038/nrneurol.2016.182
  9. Yilmaz R, Weishaupt K, Valkadinov I, et al. Quadruple genetic variants in a sporadic ALS patient. Mol Genet Genomic Med. 2022;10(7):e1953. https://doi.org/10.1002/mgg3.1953
  10. Narain P, Padhi AK, Dave U, et al. Identification and characterization of novel and rare susceptible variants in Indian amyotrophic lateral sclerosis patients. Neurogenetics. 2019;20(4):197-208.  https://doi.org/10.1007/s10048-019-00584-3
  11. Borg R, Farrugia Wismayer M, Bonavia K. Genetic analysis of ALS cases in the isolated island population of Malta. Eur J Hum Genet. 2021;29(4):604-614.  https://doi.org/10.1038/s41431-020-00767-9
  12. Wang F, Liu X, He J, et al. Analysis of ERBB4 Variants in Amyotrophic Lateral Sclerosis Within a Chinese Cohort. Front Neurol. 2022;13:865264. https://doi.org/10.3389/fneur.2022.865264
  13. Al Khleifat A, Iacoangeli A, van Vugt JJFA. Structural variation analysis of 6,500 whole genome sequences in amyotrophic lateral sclerosis. NPJ Genom Med. 2022;7(1):8.  https://doi.org/10.1038/s41525-021-00267-9
  14. Van Daele SH, Moisse M, van Vugt JJFA, et al. Genetic variability in sporadic amyotrophic lateral sclerosis. Brain. 2023;146(9):3760-3769. https://doi.org/10.1093/brain/awad120
  15. Zhang N, Chen KL, Huang YY, et al. A new ERBB4 variant in amyotrophic lateral sclerosis type 19: Case report and review of the literature. Clin Neurol Neurosurg. 2023;227:107636. https://doi.org/10.1016/j.clineuro.2023.107636
  16. Sun L, Cheng B, Zhou Y, et al. ErbB4 Mutation that Decreased NRG1-ErbB4 Signaling Involved in the Pathogenesis of Amyotrophic Lateral Sclerosis/Frontotemporal Dementia. J Alzheimers Dis. 2020;74(2):535-544. 

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.